The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline thrombophilia gene alterations and thrombosis rates among patients with advanced germ cell tumors treated with chemotherapy.
 
Landon Carter Brown
Consulting or Advisory Role - Seattle Genetics/Astellas
 
Myra M. Robinson
No Relationships to Disclose
 
Michael Joseph McCormack
No Relationships to Disclose
 
Nury Steuerwald
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Astellas Pharma; Camurus; CARsgen Therapeutics; Endocyte (Inst); Immatics; Lilly
Research Funding - Various (Inst)
 
Rupali Bose
Honoraria - Abbvie (I); Adaptive Biotechnologies (I); ADC Therapeutics (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Genmab (I); Gilead Sciences (I); Janssen Oncology (I); Karyopharm Therapeutics (I); Loxo/Lilly (I); Roche/Genentech (I); Seagen (I); TG Therapeutics (I)
Consulting or Advisory Role - Abbvie (I); Adaptive Biotechnologies (I); ADC Therapeutics (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Genmab (I); Gilead Sciences (I); Janssen Oncology (I); Karyopharm Therapeutics (I); Loxo/Lilly (I); Roche/Genentech (I); Seagen (I); TG Therapeutics (I)
Speakers' Bureau - Abbvie (I); AstraZeneca (I); Bristol-Myers Squibb (I); Epizyme (I); Gilead Sciences (I); Janssen Oncology (I)
Research Funding - Bristol-Myers Squibb (I); Genentech (I); Gilead Sciences (I); TG Therapeutics (I)
 
Brittany Neelands
No Relationships to Disclose
 
Tobi Akinyelu
No Relationships to Disclose
 
Chad Livasy
No Relationships to Disclose
 
Wencheng Li
No Relationships to Disclose
 
Nathanael C. Haynes
No Relationships to Disclose
 
Claud Grigg
Consulting or Advisory Role - Bayer; EMD Serono; Exelixis; Exelixis; Pfizer/EMD Serono; Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Calithera Biosciences; Pfizer
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst)
 
Peter E Clark
Consulting or Advisory Role - Merck
(OPTIONAL) Uncompensated Relationships - Galil Medical
 
Jai Narendra Patel
Honoraria - Clarified Precision Medicine; VieCure
Consulting or Advisory Role - Clarified Precision Medicine; VieCure
Research Funding - American Association for Cancer Research (Inst); Bristol-Myers Squibb (Inst); Professional Compounding Centers of America (Inst); Symberix (Inst)
 
Earle F Burgess
Stock and Other Ownership Interests - Arvinas; Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Macrogenics; Medtronic
Honoraria - Exelixis; Janssen Oncology; Merck; Novartis; Pfizer
Consulting or Advisory Role - Johnson & Johnson
Speakers' Bureau - AstraZeneca; Exelixis
Research Funding - Astellas Pharma; Pfizer